JPRN-UMIN000025416已完成1 期
The feasibility phase II trial for multidisciplinary therapy for borderline resectable pancreatic cancer. - GEM/nPTX & SURGERY trial
Japanese foundation for cancer research, Cancer institute hospital0 个研究点目标入组 60 人开始时间: 2016年12月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Distant metastasis 2)Unresectable local invasion 3)Previous chemotherapy performed within 3 months
研究者
相似试验
进行中（未招募）
1 期
A study with the aim to evaluate the antitumor activity of a new association of oral drugs, lenalidomide and clarithromycin in patients with lymphoma (MALT), when standard treatment with radiation therapy, chemotherapy and / or immunotherapy have shown a lack of efficacy.Patients with lymphoid tissue lymphoma mucosa-associated (MALT) for which the standard treatments with radiotherapy, chemotherapy and / or immunotherapy show lack of efficacy.MedDRA version: 21.0Level: PTClassification code 10015823Term: Extranodal marginal zone B-cell lymphoma (MALT type) recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10015824Term: Extranodal marginal zone B-cell lymphoma (MALT type) refractorySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-003168-35-ITIELSG - INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP68
进行中（未招募）
1 期
A phase II trial clarithromycin + lenalidomide combination:for patients with relapsed/refractory extranodal marginal zone lymphomaextranodal marginal zone lymphoma (MALT)EUCTR2015-003168-35-ATIELSG International Extranodale Lymphoma Study Group; Instituto Oncologico della Svizzera Italiana,68
进行中（未招募）
不适用
Clinical trial to evaluate the feasibility and safety of the intracerebral infusion of stem cells in patients with cerebral strokeEUCTR2011-001393-26-ESFundación para la Investigación Biomédica del Hospital Clínico San Carlos
进行中（未招募）
1 期
The proposal is to join a Phase II clinical trial to test the feasibility and safety of a new therapeutic application based on the use of mesenchymal stem cells derived from adipose tissue (ASC) that is being made in various international hospitals.EUCTR2010-024331-16-ESFundación para la Investigación Biomédica del Hospital Universitario La Paz
进行中（未招募）
1 期
The proposal is to join a clinical research study in Phase IIa to test the feasibility and safety of a new therapeutic application based on the use of stem cells derived from lipoaspirate (ASC).Keratopathy associated with bilateral limbic insufficiency.EUCTR2010-024328-53-ESFundación para la Investigación Biomédica del Hospital Universitario La Paz